학술논문

Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial

Document Type

Article

Author

Richeldi, L.; Fernández Pérez, E.R.; Costabel, U.; Albera, C.; Lederer, D.J.; Flaherty, K.R.; Ettinger, N.; Perez, R.; Scholand, M.B.; Goldin, J.; Peony Yu, K.-H.; Neff, T.; Porter, S.; Zhong, M.; Gorina, E.; Kouchakji, E.; Raghu, G.

Source

In: The Lancet Respiratory Medicine. (The Lancet Respiratory Medicine, January 2020, 8(1):25-33)

Subject

Language

English

ISSN

22132619
22132600

Online Access

Full Text (ScienceDirect 종량제) Full Text (Clinical Key) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송